The study evaluate that fluconazole is recommended as first–line treatment in invasive candidiasis in children and infants. However, result suggest that the fluconazole concentration is not sufficient in pediatric cancer patients with the currently recommended dose regimen, and a higher fluconazole dose is required to achieve adequate drug exposure.

READ FULL ARTICLE Curated publisher From Mdlinx